Literature DB >> 2871163

Uridine-induced hyperthermia in the rabbit.

J C Cradock, B R Vishnuvajjala, T F Chin, H D Hochstein, S K Ackerman.   

Abstract

Uridine injection in 0.6% saline elevated rabbit temperatures (mean = 0.9 degree C) in the USP XX pyrogen test. Hyperthermia was delayed in onset and peaking 3-4 h post injection, but the injection was negative in the limulus amoebocyte lysate (LAL) assay. Uridine from five lots of different sources exceeded USP XX limits in the rabbit pyrogen test and proved negative in the LAL assay. Because the dose of uridine was high, several procedures were used to determine if an impurity was the cause of temperature elevation. Uridine remained pyrogenic in spite of ultrafiltration (10 000 nominal mol. wt), recrystallization and preparative scale HPLC. Sterile filtration and autoclaving also did not affect the response. Hyperthermia, therefore, appears to be an inherent property of uridine. Uridine was also found to release endogenous pyrogen in-vitro from human mononuclear cells. Uridine has been reported to induce fever in man, thus the USP rabbit pyrogen test predicted for the clinical response.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871163     DOI: 10.1111/j.2042-7158.1986.tb04552.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Uridine-induced hypothermia in mice and rats in relation to plasma and tissue levels of uridine and its metabolites.

Authors:  G J Peters; C J van Groeningen; E J Laurensse; J Lankelma; A Leyva; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Effect of pyrimidine nucleosides on body temperatures of man and rabbit in relation to pharmacokinetic data.

Authors:  G J Peters; C J van Groeningen; E Laurensse; I Kraal; A Leyva; J Lankelma; H M Pinedo
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

3.  Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy.

Authors:  J P Sommadossi; E M Cretton; L B Kidd; H M McClure; D C Anderson; M H el Kouni
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

4.  In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.

Authors:  G J Peters; J van Dijk; E Laurensse; C J van Groeningen; J Lankelma; A Leyva; J C Nadal; H M Pinedo
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.